| Re-Imagining CT Methodology |
SU-KL-DBRB-5: Emerging and Preclinical Modalities
A Computational Forward Model for Propagation-Based Phase Contrast CT in a Cone Beam Geometry |
Elisabeth Shanblatt |
|
| Emerging Modalities and Platforms |
SU-KL-DBRB-1: Emerging and Preclinical Modalities
BEST IN PHYSICS (IMAGING): Optimization of a Table-Top X-Ray Fluorescence Computed Tomography (XFCT) System |
Chelsea Dunning |
|
SU-KL-DBRB-8: Emerging and Preclinical Modalities
Analysis of Pharmacokinetic Modeling and Doxycycline to Quantify Tumor Metabolism Variations Using Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Imaging |
Joshua Niedzielski |
|
SU-KL-DBRB-9: Emerging and Preclinical Modalities
Hyperpolarized Magnetic Resonance Imaging Reveals Transformations in Pyruvate Metabolism Prior to Anatomic Changes in Patient-Derived Glioblastoma Models |
Travis Salzillo |
|
SU-KL-DBRB-11: Emerging and Preclinical Modalities
Characterizing Thrombus Age and Molecular Organization Using Magnetic Nanoparticle Spectroscopy |
John Weaver |
|
| Response Assessment |
SU-L-KDBRC-6: Imaging for Treatment Response Assessment
Apparent Diffusion Coefficient (ADC) Measured by Diffusion Weighted MRI Was Highly Correlated with Tumor Cell Survival in Non-Small Cell Lung Cancer (NSCLC) Cell Lines Under Stereotactic Body Radiotherapy (SBRT) Regimens |
Yuenan Wang |
|